Study on the Effectiveness and Safety of Oros Hydromorphone in Pain Management Among Patients With Cancer Pain
This study has been terminated.
(the study was stopped due to non-availability of 4mg)
Sponsor:
Janssen Pharmaceutica
Information provided by (Responsible Party):
Janssen Pharmaceutica
ClinicalTrials.gov Identifier:
NCT01648699
First received: July 20, 2012
Last updated: August 10, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | September 2010 |
| Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |